Clinical trial
Tenofovir in HIV/HBV Coinfection
NCT00192595 · Kirby Institute, Other · Completed
Key facts
| NCT number | NCT00192595 |
|---|---|
| Title | Tenofovir in HIV/HBV Coinfection |
| Official title | Virological and Clinical Anti-HBV Efficacy of Tenofovir in Antiretroviral naïve Patients With HIV/HBV Co-infection |
| Acronym | TICO |
| Lead sponsor | Kirby Institute, Other |
| Collaborators | The University of New South Wales Gilead Sciences Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infection, Hepatitis B Coinfection |
| Intervention type | Drug |
| Interventions | Tenofovir, Zidovudine (AZT), lamivudine (LAM), efavirenz (EFV) |
| Enrollment | 36 |
| Start date | Jan 1, 2004 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Sep 19, 2005 |
| Last update posted | Apr 1, 2015 |
| Countries | Australia, Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: